Staar Surgical Recap

What is your opinion of Staar Surgical?

Staar Surgical

NASDAQ:STAA - Jul. 23rd 8:04pm

$ 12.83 -0.23 (-1.76%)

Shares of Staar Surgical – a $493 million market cap Medical Instruments & Supplies company – have fallen -1.76 percent to $12.83 as of 4:00 PM. With the current share price, Staar Surgical has a P/E Ratio of 263.16.

STAAR Surgical was incorporated in the state of California in 1982. It was reincorporated in Delaware in 1986. The Company designs, develops, manufactures and sells implantable lenses for the eye. The Company is a maker of lenses used in corrective surgery, and it also makes lenses for use in surgery that treats cataracts. All of the lenses it make are foldable, which permits the surgeon to insert them through a small incision during minimally invasive surgery. The Company maintains manufacturing and administrative facilities in the United States, Switzerland and Japan. The Company operates its administrative headquarters and a manufacturing facility in Monrovia, California. The Monrovia manufacturing facility principally makes Collamer and silicone IOLs and injector systems for IOLs and ICLs. The Company also currently manufactures the raw material for Collamer lenses (both IOLs and ICLs) and the AquaFlow Device (for the treatment of glaucoma) in a facility in Aliso Viejo, California. It operates an administrative, manufacturing and distribution facility in Nidau, Switzerland under its wholly owned subsidiary, STAAR Surgical AG. The Nidau manufacturing facility makes all of STAAR's Visian ICL products and also manufactures the AquaFlow Device. It operates administrative, manufacturing and distribution facilities in Japan under its wholly owned subsidiary, STAAR Japan Inc. STAAR Japan's administrative facility is located in Shin-Urayasu and its manufacturing and distribution facility is located in Ichikawa City. STAAR currently assembles all of its preloaded IOL injectors at the Ichikawa City facility. The Company competes with Novartis, Abbott and Valeant. The Company is subject to periodic inspection by the FDA for compliance with the FDA's quality system regulations and requirements, such as restrictions on advertising and promotion.

Find out more about Staar Surgical.


Staar Surgical Stock Price

Staar Surgical’s (NASDAQ:STAA) previous close price was $13.06.

Monrovia, CA | 4 hours ago

Financials
Staar Surgical